Further understanding of the mechanisms by which TLR2 and other components of innate immunity respond to B. cereus and other organisms in the eye could facilitate the development of new therapeutic regimens to hamper inflammation and prevent vision loss during this blinding infection. The gene discussed is TLR2; the disease is infection.